07 June 2020
Visiongain has launched a new pharma report Dental Fluoride Treatment Market Report 2020-2030: Forecasts by Product (Gels, Mouth Rinse, Supplements, Toothpaste, Varnish, Others), and Geography (North America, Latin America, Europe, Asia Pacific, MEA).
The global dental fluoride treatment market is anticipated to grow at a lucrative CAGR of xyz% and anticipated to reach USD xyz billion by 2020 on account of the rising prevalence of dental caries and growing awareness towards oral hygiene
Moreover, an increase in the intake of sugary food and drinks, such as soft drinks, candy, flavored yogurt, cookies, and fruit drinks, is expected to fuel market growth. Sugary food and drinks release acid when the bacteria present in the mouth are broken down. Eventually, this acid dissolves the tooth enamel, causing tooth decay.
According to an article published by the Wolfson Institute of Preventive Medicine in the United Kingdom, almost 1 in every 3 adults and 1 in every 4 children suffer from some type of tooth decay. Tooth decay can cause dental abscesses and eventually lead to tooth extraction.
Moreover, dental hypersensitivity is one of the most common dental conditions and, according to data from the FDI World Dental Federation, its prevalence ranges from 3% to 57% depending on the method of investigation and population studied. As a result, a high prevalence of dental decay and hypersensitivity is expected to increase the demand for fluoride treatments.
North America dominated the global dental fluoride treatment market owing to increasing awareness regarding oral health hygiene, increasing healthcare expenditure, and the presence of well-established healthcare infrastructure. For instance, as per the American Dental Association, in 2018 an estimate of 199,486 dentists practiced dentistry which results in 61 dentists per 100,000 inhabitants in the United States. with such a huge dentist in this region will boost the dental fluoride treatment market. Asia Pacific region is expected to experience the highest growth in terms of CAGR over the forecast period owing to growing expenditure towards oral hygiene coupled with growing medical tourism market across the region. Additionally, high prevalence of dental caries in emerging economies due to high tobacco consumption and poor lifestyles and untapped nations in this region have been attracting investments by global players and this is expected to boost the dental fluoride treatment market growth over the forecast period.
Currently, key players are forming various strategies such as acquisitions, mergers, partnerships, collaborations, and launching new products to strengthen their position in the global dental fluoride treatment market. Companies are also expanding their R&D, distribution, and management facilities to expand their business and to hold a competitive edge in the dental fluoride treatment market.
The comprehensive market report features companies such as 3M, Centrix, Colgate, DÃœRRDENTAL, Dentsply Sirona, DMG Dental, Elevate Oral Care, GC Corporation, Ivoclar Vivadent, Medicom, MPL, Philips, Premier Dental, Preventech, Pulpdent Corporation, Ultradent Products, VOCO, Water Pik, Young Dental, among other prominent players. Also the research study offers market estimation and forecast for the period ranging 2020-2030 for global markets such as North America, Latin America, Europe, Asia Pacific and MEA along with regional sub-markets as U.S., Canada, Brazil, Mexico, Germany, UK, France, Italy, Spain, Russia, India, Japan, China, Australia, ASEAN, GCC and South Africa.
Notes for Editors
If you are interested in a more detailed overview of this report, please send an e-mail to email@example.com or call her on +44 (0) 20 7549 9987.
Visiongain is one of the fastest growing and most innovative independent media companies in Europe. Based in London, UK, Visiongain produces a host of business-to-business reports focusing on the automotive, aviation, chemicals, cyber, defence, energy, food & drink, materials, packaging, pharmaceutical and utilities sectors.
Visiongain publishes reports produced by analysts who are qualified experts in their field. Visiongain has firmly established itself as the first port of call for the business professional who needs independent, high-quality, original material to rely and depend on.
Rising preference for personalised medicine in developed as well developing economies coupled with increasing investment by biotechnological and pharmaceutical companies for drug discovery is expected to increase RNA analysis/transcriptomics market concentration over the forecast period. In order to increase the reliability and success rate of the drug production process.
30 November 2020
The market is forecasted for the next ten years based on market growth within each segment of the blood plasma products. The report study aims to explore the market drivers, restraints and also market opportunities facing blood plasma product stakeholders in different geographic areas.
26 November 2020
Molecular diagnostics are rapidly transforming drug development and patient selection: trials with biomarkers have higher success rates than those without, and combining patients with a proven biomarker allows efficient trials to be conducted in rare cancers.
26 November 2020
Growing demand for cost-effective drugs; rising prevalence of chronic diseases; mounting investment in drug R&D by biopharmaceutical companies; new product launches and rising acceptance of biosimilars in North America region are some of the major factors that propel the biosimilars market growth.